About St. Luke's Hospital Immunotherapy Program
Aurora St. Luke's Medical Center is a private hospital located in Milwaukee, Wisconsin. It is one of the 15 hospitals of Aurora Health Care, a non-profit health care system founded in 1984 and headquartered in Milwaukee, Wisconsin.
Clinical Trials at St. Luke's Hospital Immunotherapy Program
During the past decade, St. Luke's Hospital Immunotherapy Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St. Luke's Hospital Immunotherapy Program
According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital Immunotherapy Program" are
"Metastatic Androgen Independent Prostate Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Hospital Immunotherapy Program" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Hospital Immunotherapy Program
Most popular intervention types in "St. Luke's Hospital Immunotherapy Program" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "APC-Placebo" (1 trials), "APC8015F" (1 trials) and "Sipuleucel-T" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Hospital Immunotherapy Program
The vast majority of trials in "St. Luke's Hospital Immunotherapy Program" are
2 trials for "Male" genders.
Clinical Trials Status at St. Luke's Hospital Immunotherapy Program
Currently, there are NaN active trials in "St. Luke's Hospital Immunotherapy Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in St. Luke's Hospital Immunotherapy Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Hospital Immunotherapy Program, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".